Hancock Whitney’s NuVasive, Inc. NUVA Stock Holding History

Hancock Whitney’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,387	Closed	-$303K	–	832
2020 Q4	$303K	Sell	5,387 -293	-5%	-$14.4K	0.01%	641
2020 Q3	$276K	Sell	5,680 -12	-0.2%	-$647	0.01%	649
2020 Q2	$317K	Sell	5,692 -2,426	-30%	-$140K	0.01%	606
2020 Q1	$411K	Buy	8,118 +2,302	+40%	+$154K	0.02%	554
2019 Q4	$450K	Sell	5,816 -3,569	-38%	-$252K	0.01%	587
2019 Q3	$595K	Sell	9,385 -371	-4%	-$23.2K	0.02%	550
2019 Q2	$571K	Buy	9,756 +121	+1%	+$7.14K	0.02%	591
2019 Q1	$547K	Buy	9,635 +2,129	+28%	+$113K	0.02%	603
2018 Q4	$372K	Sell	7,506 -3,359	-31%	-$202K	0.01%	675
2018 Q3	$771K	Buy	+10,865	New	+$691K	0.02%	535

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hancock Whitney's NUVA Position: Q1 2021 in Review

Hancock Whitney sold out of NuVasive, Inc. (NUVA) in Q1 2021, closing a stake of 5,387 shares — an estimated $303K sold.

Hancock Whitney first reported a position in NUVA in Q3 2018 and held it in 10 quarters. The position peaked at $771K in Q3 2018. 261 funds tracked by Wall St. Rank hold NUVA as of Q1 2021.

Hancock Whitney reported no remaining NuVasive, Inc. position as of Q1 2021 after selling out during the quarter.
Hancock Whitney sold 5,387 NuVasive, Inc. shares in Q1 2021, an estimated $303K.
Hancock Whitney first reported a position in NuVasive, Inc. in Q3 2018 and held it in 10 quarters.
Hancock Whitney's NuVasive, Inc. position peaked at $771K in Q3 2018.
261 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2021.

Based on Hancock Whitney's 13F filing for Q1 2021, filed 14 May 2021.